Converge Bio Waxay Adeegsataa AI Si Ay U Horumariso Daawaynta Kansarka Iyada Oo Hal Dalab Ah
Shirkad Israa'iili ah oo la yiraahdo Converge Bio ayaa horumarisay daawada kansarka ee cetuximab iyadoo isticmaalaysa AI, taasoo soo saartay 100,000 oo qof oo ka mid ah unugyada difaaca jirka (antibodies) isla markaana ay heshay mid ka xoog…
